Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.

Summary

Primary: This study is being conducted to evaluate if AVE1625 is safe and tolerated in patients with Alzheimer's disease that is not too severe. There is also evaluation of whether patients who take the study medication improve compared to patients who take a placebo (sugar pill). Secondary:The study will also evaluate the blood levels of the study medication, AVE1625 in patients who join the study.

Timeline

Start

2006-09

Primary completion

2007-07

Completion

2007-07

Drugs

Indications